Professional Documents
Culture Documents
CLICK TO VIEW
Table of Contents 2 List of Tables & Charts 3 Study Overview 4 Sample Text, Table & Chart 5 Sample Profile, Table & Forecast 6 Order Form 7 About Freedonia, Custom Research, Related Studies, Corporate Use License 8
Biocompatible Materials
US Industry Study with Forecasts to 2010 & 2015
Study #2111 | September 2006 | $4400 | 264 pages
www.freedoniagroup.com
Cleveland, OH 44143-2326 USA Toll Free US Tel: 800.927.5900 or +1 440.684.9600 Fax: +1 440.646.0484 E-mail: info@freedoniagroup.com
Biocompatible Materials
US Industry Study with Forecasts to 2010 & 2015
Table of Contents
IntroductIon ExEcutIvE Summary markEt EnvIronmEnt
General ...................................................4 Economic Factors ......................................5 Demographic Patterns ................................8 Health Care Trends .................................. 10 Medical Conditions ............................... 11 Chronic Conditions ............................ 12 Acute Conditions .............................. 14 Health Insurance & Reimbursement ........ 15 National Health Expenditures ................. 18 Medical Providers ................................. 21 Hospitals......................................... 24 Physicians ....................................... 24 Dentists .......................................... 25 Outpatient Facilities ......................... 26 Skilled Nursing Homes ....................... 27 Patient Activity ................................... 27 Surgical Procedures ........................... 29 Outpatient Episodes .......................... 29 Medical Product Shipments .................... 31 Pharmaceuticals & Biologicals ............ 32 Surgical & Medical Instruments ........... 33 Surgical Appliances & Supplies............ 34 Electromedical Equipment .................. 34 In Vitro Diagnostic Products ............... 35 Dental Products ................................ 35 Ophthalmic Goods............................. 36 Other Medical Products ...................... 36 Regulatory Considerations ........................ 37 Medical Devices ................................... 37 Drug Delivery Systems .......................... 39 Historical Demand Patterns....................... 40 Pricing Trends......................................... 42 US Trade ................................................ 42 International Markets .............................. 44 Polyvinyl Chloride ................................ 57 Environmental & Safety Concerns ........ 58 Production....................................... 60 Resin Properties ............................... 60 Producers & Compounds..................... 61 Fluoropolymers .................................... 63 PTFE ............................................... 64 Modified PTFE .................................. 65 FEP ................................................ 66 ETFE ............................................... 67 PFA ................................................ 67 MFA................................................ 67 Polyurethane ....................................... 68 Production & Properties ..................... 69 Applications .................................... 69 Producers & Compounds..................... 70 Polycarbonate ..................................... 71 Production....................................... 72 Applications .................................... 73 Producers & Compounds..................... 73 Silicone .............................................. 74 Production....................................... 75 Applications .................................... 76 Producers & Compounds..................... 79 Acrylic Compounds ............................... 79 Applications .................................... 81 Producers & Compounds..................... 83 Thermoplastic Polyesters ....................... 84 Types of Compounds.......................... 85 Properties ....................................... 86 Applications .................................... 87 Producers & Compounds..................... 88 Polypropylene ..................................... 89 Production & Types ........................... 90 Applications .................................... 91 Producers & Compounds..................... 91 Low Density Polyethylenes .................... 92 Production & Types ........................... 93 Properties ....................................... 95 Applications .................................... 96 Producers & Compounds..................... 96 Nylon................................................. 97 Production & Types ........................... 97 Applications .................................... 98 Producers & Compounds..................... 99 Sulfone Resins ..................................... 99 High Density Polyethylenes ................. 101 Other Synthetic Biocompatible Polymers 103 Natural Polymers ................................... 111 Cellulose Polymers ............................. 113 Drug Delivery ................................. 114 Surgical Appliances & Supplies.......... 116 Collagen ........................................... 117 Surgical Appliances & Supplies.......... 118 Dental Products .............................. 119 Producers ...................................... 119 Starch Blends .................................... 121 Other Natural Polymers .................... 123 Hyaluronic Acid ........................... 124 Alginates ................................... 126 Carrageenan ............................... 127 Other Natural Polymers ................. 128 Biocompatible Metals ............................ 130 Precious Metals ................................. 132 Gold ............................................. 133 Silver............................................ 133 Other Precious Metals ...................... 135 Stainless Steel................................... 136 Titanium .......................................... 139 Other Biocompatible Metals ................. 143 Biocompatible Ceramics ......................... 144 Porcelain .......................................... 146 Alumina ........................................... 146 Hydroxyapatite .................................. 147 Zirconia............................................ 147 Other Ceramics & Related Materials ....... 147 Surgical Appliances & Supplies ............. 148 Dental Products ................................. 150 Electromedical Equipment ................... 152
aPPLIcatIonS
General ............................................... 153 Surgical Appliances & Supplies ................ 155 Surgical & Medical Instruments ............... 162 Dental Products .................................... 164 Drug Delivery ....................................... 167 Electromedical Equipment ...................... 172 In Vitro Diagnostic Products ................... 174 Ophthalmic Goods ................................. 176
InduStry StructurE
BIocomPatIBLE matErIaLS
General ................................................. 46 Synthetic Polymers .................................. 48 Thermoplastic Elastomers ...................... 51 Silicone Elastomers ........................... 53 Styrene Block Copolymers .................. 54 Thermoplastic Copolyesters ................ 55 Thermoplastic Polyamides .................. 55 Thermoplastic Polyolefins ................... 56 Thermoplastic Polyurethanes .............. 56 Thermoplastic Vulcanizates ................ 56
General ............................................... 178 Market Share ........................................ 180 Competitive Strategies ........................... 181 Mergers & Acquisitions........................... 186 Licensing & Related Agreements .............. 189 Research & Development ........................ 193 Channels of Distribution......................... 194 Marketing ............................................ 196 Manufacturing ...................................... 197
comPany ProfILES
(listed on next page)
Biocompatible Materials
US Industry Study with Forecasts to 2010 & 2015
comPany ProfILES
Allegheny Technologies ......................... 200 Angiotech Pharmaceuticals ..................... 205 Arkema SA ........................................... 207 Artimplant AB ...................................... 209 BASF AG .............................................. 211 Bayer AG ............................................. 213 BioSyntech Incorporated ........................ 215 Celanese Corporation ............................. 216 Chevron Phillips Chemical ....................... 218 Dow Chemical ....................................... 219 Dow Corning ........................................ 221 DuPont (EI) de Nemours ......................... 223 Eastman Chemical ................................ 225 Exxon Mobil ......................................... 227 FMC Corporation.................................... 228 General Electric .................................... 230 Genzyme Corporation ............................. 232 Georgia Gulf ......................................... 233 Gore (WL) & Associates .......................... 234 Imperial Chemical Industries................... 237 Ineos Group ......................................... 239 Integra LifeSciences ............................. 240 International Specialty Products .............. 242 Johnson & Johnson ............................... 243 Johnson Matthey plc ............................. 244 Lyondell Chemical ................................ 245 Memry Corporation ................................ 246 Morgan Crucible .................................... 249 Orthovita Incorporated .......................... 251 OxyVinyls LP ........................................ 253 PolyOne Corporation .............................. 254 Saint-Gobain ........................................ 255 Solvay SA ............................................ 257 Total SA............................................... 260 Westlake Plastics .................................. 261 Additional Companies ............................ 262
National Health Expenditures ............. 21 Selected Medical Providers by Type ...... 23 Selected Patient Activity by Type ........ 28 Medical Product Shipments by Type ..... 32 Biocompatible Material Demand, 1995-2005 ................................. 41 10 US Trade in Biocompatible Materials .... 43 11 World Biocompatible Material Demand by Region ......................... 45
5 6 7 8 9
matErIaLS
List of Tables/Charts
ExEcutIvE Summary
1 Summary Table ...................................3
markEt EnvIronmEnt
1 Macroeconomic Indicators ....................7 2 Resident Population by Age Group .........9 3 Medical Conditions by Duration & Type ........................ 12 4 Health Insurance Coverage ................. 18
1 Biocompatible Material Demand by Type ............................ 47 Cht Biocompatible Material Demand by Type, 2005 ................... 47 2 Synthetic Biocompatible Polymer Demand by Type ................ 50 Cht Synthetic Biocompatible Polymer Demand by Type, 2005 ................... 51 3 Biocompatible Thermoplastic Elastomer Demand by Application .... 53 4 Biocompatible Polyvinyl Chloride Demand by Application ...... 58 5 Biocompatible Fluoropolymer Demand by Application .................. 64 6 Biocompatible Polyurethane Demand by Application .................. 68 7 Biocompatible Polycarbonate Demand by Application .................. 72 8 Biocompatible Silicone Demand by Application .................. 75 9 Biocompatible Acrylic Demand by Application .................. 81 10 Biocompatible Thermoplastic Polyester Demand by Application ..... 85 11 Biocompatible Polypropylene Demand by Application .................. 89 12 Biocompatible Low Density Polyethylenes Demand by Application .............................. 93 13 Biocompatible Nylon Demand by Application .................. 97 14 Biocompatible Sulfone Resin Demand by Application ........ 101 15 Biocompatible High Density Polyethylenes Demand by Application ............................ 103 16 Other Synthetic Biocompatible Polymer Demand by Application ..... 105 17 Natural Biocompatible Polymer Demand by Type .......................... 112 Cht Natural Biocompatible Polymer Demand by Type, 2005 ................. 112
18 Biocompatible Cellulose Polymer Demand by Application ................ 113 19 Biocompatible Collagen Demand by Application ................ 118 20 Biocompatible Starch Blend Demand by Application ................ 123 21 Other Natural Biocompatible Polymer Demand by Type & Application .................. 124 22 Biocompatible Metal Demand by Type .......................... 131 Cht Biocompatible Metal Demand by Type, 2005 ............................. 131 23 Biocompatible Precious Metal Demand by Application ........ 132 24 Biocompatible Stainless Steel Demand by Application ......... 139 25 Biocompatible Titanium Demand by Application ................ 143 26 Other Biocompatible Metal Demand by Application ................ 144 27 Biocompatible Ceramic Demand by Type & Application .................. 145
aPPLIcatIonS
1 Biocompatible Material Demand by Application ................ 154 Cht Biocompatible Material Demand by Application, 2005 ........ 154 2 Biocompatible Material Demand in Surgical Appliances & Supplies ...... 156 3 Biocompatible Material Demand in Surgical & Medical Instruments...... 164 4 Biocompatible Material Demand in Dental Products .......... 165 5 Biocompatible Material Demand in Drug Delivery .............. 168 6 Biocompatible Material Demand in Electromedical Equipment ......... 173 7 Biocompatible Material Demand in In Vitro Diagnostic Products.......... 175 8 Biocompatible Material Demand in Ophthalmic Goods .................... 177
InduStry StructurE
1 US Biocompatible Material Sales by Company, 2005 ............... 179 Cht Biocompatible Material Market Share, 2005 ...................... 181 2 Selected Acquisitions & Divestitures ................................ 188 3 Selected Cooperative Agreements ...... 190
Biocompatible Materials
US Industry Study with Forecasts to 2010 & 2015
Spurred by expanding applications in cosmetic surgery and wound management, hyaluronic acid and collagen will generate the fastest gains in US demand among biocompatible natural polymers.
uses will weaken the growth potential of stainless steel and other biocompatible metals, such as cobalt chromium alloys.
Biocompatible Materials
US Industry Study with Forecasts to 2010 & 2015
table iii-2 sYNtHetic biocompatible polYmer DemaND bY tYpe (million dollars) Item Medical Product Shipments (bil $) $ biocomp polymers/000$ shpts 1995 2000 2005 2010 2015 152 3.98 245 3.61 379 3.75 530 3.72 735 3.58
biocompatible materials
Synthetic Biocompatible Polymers 605 885 1420 1970 2630 Thermoplastic Elastomers (TPEs) 72 109 191 285 400 synthetic polymers Polyvinyl Chloride (PVC) 90 119 179 223 265 Synthetic polymers will remain the dominant materials employed Fluoropolymers 70 103 161 219 290 in biocompatible products. Total synthetic polymer demand in biocomPolyurethane (PUR) 45 88 149 210 283 patible applications is projected to increase 4.2 percent annually to 695 Polycarbonate (PC) 59 83 134 205 287 million pounds, valued at nearly $2 billion, in 2010. These amounts Silicone will 50 72 101 150 220 correspond to nearly 72 percent of the volume and almost 53 percentAcrylic of 52 71 100 130 166 the value of biocompatible materials consumed in the US. Thermoplastic Polyesters (TPs) 30 45 77 106 140 Polypropylene (PP) 26 36 66 92 125 The leading position of synthetic polymers in various medical, Low Density Polyethylene (LDPE) 27 34 55 71 91 dental pharmaceutical segments reflects ongoing innovations and im-Nylon 19 26 41 52 64 provements in compounds. Technological advances have made available Sulfone Resins 12 18 31 46 65 resins that meet the needs of end-use products as to biocompatibility,High Density Polyethylene (HDPE) 9 12 21 28 36 chemical resistance, infection resistance, clarity, sterilization compatOther 44 69 114 153 198 ibility, processing ease, and overall quality and cost efficiency. All or virtually all medical tubing devices, IV containers and components, $/lb 1.69 1.92 2.51 2.83 3.09 syringe cartridges, specimen tubes, and intraocular and contact lenses, Synthetic Biocomp Polymers (mil lbs) 358 460 565 695 850 as well as a large percentage of dental materials and devices, orthopedic Demand for low density implants, drug delivery systems and wound management supplies, are polyethylenes (including composed of synthetic polymers. Further improvements and refinements conventional low density, in materials will extend the range of biocompatible products adaptable to commodity and engineered plastic resins. linear low density, ultra low
SaMPLE TExT
SaMPLE TaBLE
Growth opportunities for synthetic biocompatible polymers will extend into most classes of commodity and engineered resins. Based on cost effectiveness and the availability of improving grades, commodity resins, especially polyvinyl chloride, will continue to dominate low- and medium-value applications in less invasive supplies and devices, such as IV containers and components. Conversely, demand for products with high biocompatibility requirements, including dental and orthopedic implants, and injectable drug delivery systems, will be met mostly through engineered plastics. Thermoplastic elastomers, fluoropolymers, thermoset polyurethanes, silicone, acrylics and thermoplastic polyesters 48
Copyright 2006 The Freedonia Group, Inc.
density and metallocene grades) in the production of biocompatible products is projected to increase 3.6 percent annually to 69.8 million pounds, valued at $71 million, in 2010. Fiber applications in bandages, wound dressings and incontinence garments will lead gains. In other biocompatible products adaptable to LDPEs, such as ... --Section III, pg. 92
Biocompatible Materials
US Industry Study with Forecasts to 2010 & 2015
table iV-6 biocompatible material DemaND iN electromeDical eQUipmeNt (million dollars) 1995 2000 2005 2010 2015 24.0 18.0 5.3 5.5 0.2 0.1 6.9 2.0 1.2 0.2 0.6 4.0 37.0 27.0 9.1 7.4 0.3 0.2 10.0 3.0 1.8 0.3 0.9 7.0 61.0 43.0 14.4 12.2 0.5 0.4 15.5 5.0 2.3 1.2 1.5 13.0 87.0 120.0 58.0 76.0 20.3 28.3 15.7 19.0 0.8 1.2 0.5 0.6 20.7 26.9 7.0 9.0 2.9 3.6 1.6 2.2 2.5 3.2 22.0 35.0
COMPANY PROFILES
Orthovita Incorporated 45 Great Valley Parkway Malvern, PA 19355 610-640-1775 http://www.orthovita.com Sales: $35 million (2005) US Sales: $32 million (2005) Employment: 140 (2005)
Electromedical Equipment Demand Synthetic Polymers: Thermoplastic Elastomers Nylon Acrylic High Density Polyethylene Other Metals: Stainless Steel Titanium Other Ceramics
SaMPLE TaBLE
SaMPLE PrOFILE
table V-1 biocompatible material marKet sHare, 2005 ($2.7 billion)
5.2% 4.1% GE
Key Products:synthetic, biologically active, tissue engineering products Orthovita is a biomaterials firm. The Company develops, manufactures and commercializes synthetic, biologically active, tissue engineering products for orthopedic and neurosurgical applications, including bone regeneration. Orthovitas synthetic, biologically active, tissue engineering products include VITOSS bone graft substitutes, VITOMATRIX particulate synthetic scaffold biomaterials, IMBIBE bone marrow aspirate and delivery devices, VITAGEL composite liquid surgical hemostat, CELLPACKER plasma collection systems, CORTOSS synthetic cortical bone, ALIQUOT micro delivery systems and ENDOSKELETON Others TA vertebral body replacement structural devices. VITOSS bone graft 68.5% substitute is an ultra-porous resorbable beta-tricalcium phosphate bone void filler material adaptable to a wide range of spinal, dental and orthopedic procedures. VITOMATRIX particulate synthetic scaffold biomaterials, which are based on proprietary beta-tricalcium phosphate biomaterials, are used to make VITOSS bone graft substitutes. IMBIBE bone marrow aspirate and delivery devices from Orthovita extract and harvest bone marrow from patients for use in bone 166
Copyright 2006 The Freedonia Group, Inc.
3.9%
Order InfOrmatIOn
Five Convenient Ways to Order
ONLINE: www.freedoniagroup.com MAIL: Print out and complete the order form and send to The Freedonia Group (see address at the bottom of this form) PHONE: Call toll free, 800.927.5900 (US) or +1 440.684.9600 FAX: +1 440.646.0484 (US) EMAIL: info@freedoniagroup.com
There is NO charge for handling or UPS shipping in the US. Expect delivery in 3 to 5 business days. Outside the US, Freedonia provides free airmail service. Express delivery is available at cost.
For convenience, Freedonia accepts American Express, MasterCard or Visa. Credit card purchases must include account number, expiration date and authorized signature.
Checks must be made payable in US funds, drawn against a US bank and mailed directly to The Freedonia Group. For wire transfers please contact our customer service department at info@ freedoniagroup.com. Credit cards accepted.
Save 15%
If you order three (3) different titles at the same time, you can receive a 15% discount. If your order is accompanied by a check or wire transfer, you may take a 5% cash discount (discounts do not apply to Corporate Use Licenses).
Now every decision maker in your organization can act on the key intelligence found in all Freedonia studies. For an additional $2300, companies receive unlimited use of an electronic version (PDF) of the study. Place it on your intranet, e-mail it to coworkers around the world, or print it as many times as you like,
Order fOrm
Corporate Use License (add to study price) * Additional Print Copies @ $500 each *
F-WEB.2111
Total (including selected option) $ Enclosed is my check (5% discount) drawn on a US bank and payable to The Freedonia Group, Inc., in US funds (Ohio residents add 7.75% sales tax) Bill my company American Express MasterCard Visa
MM YY
City/State/Zip Country
Credit Card #
Expiration
Phone Email
Fax
Signature
* Please check appropriate option and sign below to order an electronic version of the study.
The above captioned study may be stored on the companys intranet or shared directory, available to company employees. Copies of the study may be made, but the undersigned represents that distribution of the study will be limited to employees of the company.
The undersigned hereby represents that the above captioned study will be used by only ___ individual(s) who are employees of the company and that the study will not be loaded on a network for multiple users. In the event that usage of the study changes, the Company will promptly notify Freedonia of such change and will pay to Freedonia the appropriate fee based on Freedonias standard fee schedule then in effect. Note: Entire company corporate use license, add $2300; one additional user, add $500; two additional users, add $1000; three additional users, add $1500.
Signature
Signature
The Freedonia Group, Inc. 767 Beta Drive Cleveland, OH 44143-2326 USA Web site: www.freedoniagroup.com Tel US: 800.927.5900 or +1 440.684.9600 Fax: +1 440.646.0484 e-mail: info@freedoniagroup.com
Page 7
Other StudieS
Implantable Medical Devices
US medical implant demand will rise 9.3% yearly through 2011. Cardiac implants will remain the topselling group, led by stents and defibrillators. Bone cement, tissue and spinal implants will pace gains in the orthopedic segment. Other fast-growing types include neurological stimulators, cochlear devices and gastric bands. This study analyzes the $27.9 billion US medical implant industry, with forecasts for 2011 and 2016 by material and product. It also evaluates market share and profiles major players.
Natural Polymers
US natural polymer demand will grow 5.9% annually through 2010 based on increased food production and opportunities in packaging and medical uses. Starch and fermentation products will grow the fastest and surpass cellulose ethers as the dominant type by 2015. The food and beverage market will remain dominant while medical uses will lead gains. The study analyzes the $2.7 billion US natural polymer industry for 2010 and 2015 by product and market. It also details market share and profiles major players.
Cosmeceuticals
US cosmeceuticals demand will grow 8.5% annually, propelled by a stream of new products offering agedefying and other appearance-enhancing benefits. Skin care products will remain dominant while professional products will grow the fastest. BOTOX and hyaluronic acid will lead gains among cosmeceutical chemicals. This study analyzes the $5.4 billion US cosmeceutical industry for 2010 and 2015 by product and chemical. It also evaluates company market share and profiles leading players.
Page 8
The Freedonia Group, Inc. 767 Beta Drive Cleveland, OH 44143-2326 USA Web site: www.freedoniagroup.com Tel US: 800.927.5900 or +1 440.684.9600 Fax: +1 440.646.0484 e-mail: info@freedoniagroup.com